166 related articles for article (PubMed ID: 38289100)
1. Development of reverse genetics system for Guanarito virus: substitution of E1497K in the L protein of Guanarito virus S-26764 strain changes plaque phenotype and growth kinetics.
Taniguchi S; Maruyama J; Saito T; Littlefield K; Reyna RA; Manning JT; Huang C; Saijo M; Paessler S
J Virol; 2024 Feb; 98(2):e0196423. PubMed ID: 38289100
[TBL] [Abstract][Full Text] [Related]
2. Development of Reverse Genetics for the Prototype New World Mammarenavirus Tacaribe Virus.
Ye C; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669332
[TBL] [Abstract][Full Text] [Related]
3. An updated review and current challenges of Guanarito virus infection, Venezuelan hemorrhagic fever.
Silva-Ramos CR; Montoya-Ruíz C; Faccini-Martínez ÁA; Rodas JD
Arch Virol; 2022 Sep; 167(9):1727-1738. PubMed ID: 35579715
[TBL] [Abstract][Full Text] [Related]
4. A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.
Carnec X; Mateo M; Page A; Reynard S; Hortion J; Picard C; Yekwa E; Barrot L; Barron S; Vallve A; Raoul H; Carbonnelle C; Ferron F; Baize S
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593043
[TBL] [Abstract][Full Text] [Related]
5. An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection.
Golden JW; Beitzel B; Ladner JT; Mucker EM; Kwilas SA; Palacios G; Hooper JW
Sci Rep; 2017 Jul; 7(1):4679. PubMed ID: 28680057
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses.
Bolken TC; Laquerre S; Zhang Y; Bailey TR; Pevear DC; Kickner SS; Sperzel LE; Jones KF; Warren TK; Amanda Lund S; Kirkwood-Watts DL; King DS; Shurtleff AC; Guttieri MC; Deng Y; Bleam M; Hruby DE
Antiviral Res; 2006 Feb; 69(2):86-97. PubMed ID: 16343651
[TBL] [Abstract][Full Text] [Related]
8. Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.
Radoshitzky SR; Kuhn JH; de Kok-Mercado F; Jahrling PB; Bavari S
Expert Opin Drug Discov; 2012 Jul; 7(7):613-32. PubMed ID: 22607481
[TBL] [Abstract][Full Text] [Related]
9. Arenavirus reverse genetics for vaccine development.
Ortiz-Riaño E; Cheng BYH; Carlos de la Torre J; Martínez-Sobrido L
J Gen Virol; 2013 Jun; 94(Pt 6):1175-1188. PubMed ID: 23364194
[TBL] [Abstract][Full Text] [Related]
10. Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease.
Emonet SF; Seregin AV; Yun NE; Poussard AL; Walker AG; de la Torre JC; Paessler S
J Virol; 2011 Feb; 85(4):1473-83. PubMed ID: 21123388
[TBL] [Abstract][Full Text] [Related]
11. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
12. Experimental infection of the cane mouse Zygodontomys brevicauda (family Muridae) with guanarito virus (Arenaviridae), the etiologic agent of Venezuelan hemorrhagic fever.
Fulhorst CF; Ksiazek TG; Peters CJ; Tesh RB
J Infect Dis; 1999 Oct; 180(4):966-9. PubMed ID: 10479119
[TBL] [Abstract][Full Text] [Related]
13. Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever.
Tesh RB; Jahrling PB; Salas R; Shope RE
Am J Trop Med Hyg; 1994 Apr; 50(4):452-9. PubMed ID: 8166352
[TBL] [Abstract][Full Text] [Related]
14. T-705 (favipiravir) inhibition of arenavirus replication in cell culture.
Mendenhall M; Russell A; Juelich T; Messina EL; Smee DF; Freiberg AN; Holbrook MR; Furuta Y; de la Torre JC; Nunberg JH; Gowen BB
Antimicrob Agents Chemother; 2011 Feb; 55(2):782-7. PubMed ID: 21115797
[TBL] [Abstract][Full Text] [Related]
15. Reverse genetics approaches for the development of mammarenavirus live-attenuated vaccines.
Ye C; de la Torre JC; Martinez-Sobrido L
Curr Opin Virol; 2020 Oct; 44():66-72. PubMed ID: 32721864
[TBL] [Abstract][Full Text] [Related]
16. Genetic diversity between and within the arenavirus species indigenous to western Venezuela.
Fulhorst CF; Cajimat MN; Milazzo ML; Paredes H; de Manzione NM; Salas RA; Rollin PE; Ksiazek TG
Virology; 2008 Sep; 378(2):205-13. PubMed ID: 18586298
[TBL] [Abstract][Full Text] [Related]
17. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
Wang P; Liu Y; Zhang G; Wang S; Guo J; Cao J; Jia X; Zhang L; Xiao G; Wang W
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899092
[No Abstract] [Full Text] [Related]
18. Description and characterization of a novel live-attenuated tri-segmented Machupo virus in Guinea pigs.
Zaza AD; Herbreteau CH; Peyrefitte CN
Virol J; 2018 Jun; 15(1):99. PubMed ID: 29879985
[TBL] [Abstract][Full Text] [Related]
19. Plasmid-Based Lassa Virus Reverse Genetics.
Martínez-Sobrido L; Ye C; de la Torre JC
Methods Mol Biol; 2024; 2733():115-131. PubMed ID: 38064030
[TBL] [Abstract][Full Text] [Related]
20. Genetic diversity among Bolivian arenaviruses.
Cajimat MN; Milazzo ML; Rollin PE; Nichol ST; Bowen MD; Ksiazek TG; Fulhorst CF
Virus Res; 2009 Mar; 140(1-2):24-31. PubMed ID: 19041349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
